Skip to main content
Watch Insiders
KALV filings

Corporate insider profile

Brian Piekos Filing Activity

Latest reported as Chief Financial Officer of KalVista Pharmaceuticals, Inc. (KALV).

Purchase filings
0
Reported companies
1
Net open-market value
-$77,524.72
Latest transaction
May 22, 2026

Affiliated corporations

Reported company relationships

KALVLatest reported

KalVista Pharmaceuticals, Inc.

Chief Financial Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 22, 2026KalVista Pharmaceuticals, Inc. (KALV)Chief Financial OfficerSale1,489$26.78$39,882
Apr 17, 2026KalVista Pharmaceuticals, Inc. (KALV)Chief Financial OfficerSale1,862$20.22$37,643